Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial

Table 1 Demographic and endoscopic data of the two patient groups

Variable	mBCQT treatment (n = 68)	CT treatment (n = 68)	P value
Age (yr)	57.37 ± 11.31	60.09 ± 9.93	0.138
Gender (male:female)	40:28	32:36	0.169
Height (m)	1.64 ± 0.09	1.63 ± 0.08	0.420
Weight (kg)	64.61 ± 9.23	63.27 ± 9.69	0.409
BMI (kg/m2)	24.05 ± 2.88	23.87 ± 2.91	0.704
Smoking	12 (17.6)	14 (20.6)	0.663
Alcohol	18 (26.5)	18 (26.5)	0.999
Gastric and/or duodenal ulcer	27 (39.7)	19 (27.9)	0.147

The values are the mean ± SD, numbers only, or numbers with percentages. mBCQT: Modified bismuth-containing quadruple therapy; CT: Concomitant therapy; BMI: Body mass index.